Turn Therapeutics (TTRX) Retained Earnings (2024 - 2026)

Turn Therapeutics' Retained Earnings history runs 3 years deep, the most recent figure standing at -$23.4 million for Q1 2026.

• In Q1 2026, Retained Earnings changed N/A year-over-year to -$23.4 million; the TTM figure through Mar 2026 stood at -$23.4 million (changed N/A YoY), while the FY2025 annual figure was -$22.4 million, down 16.64% from the prior year.
• Retained Earnings for Q1 2026 stood at -$23.4 million, down from -$22.4 million in the prior quarter.
• The five-year high for Retained Earnings was -$19.2 million in Q4 2024, with the low at -$23.4 million in Q1 2026.
• The 3-year median for Retained Earnings is -$22.5 million (2025), against an average of -$21.9 million.
• Peak annual rise in Retained Earnings reached 16.64% in 2025, while the deepest fall reached 16.64% in 2025.
• Turn Therapeutics' Retained Earnings stood at -$19.2 million in 2024, then decreased by 16.64% to -$22.4 million in 2025, then declined by 4.34% to -$23.4 million in 2026.
• Business Quant data shows TTRX's Retained Earnings at -$23.4 million in Q1 2026, -$22.4 million in Q4 2025, and -$22.7 million in Q3 2025.